- Salary
- £110K–£135K
- Hiring from
- United Kingdom
- Work type
- Hybrid
- Posted
624,477 remote jobs, straight from company career pages
100% free · New jobs every minute
Show job descriptionHide job description
About Perceptic
The highest calling for AI is improving human health. We are building the AI operating system that powers drug discovery: a single intelligence layer connecting evidence, reasoning and action across the whole drug lifecycle, from scientific discovery through preclinical and clinical research to development.
Scientists and AI discovering drugs together. Not replacing the expert, but making them superhuman.
Our founders built and deployed production AI at Palantir, including the first public release of AIP. Our CEO spent twenty years across Caltech, Cambridge and ETH before leading AI strategy for life sciences. Founded less than two years ago, we are already deployed with mid to top tier pharma and biotech on live programmes.
The opportunity
Our first customers were won by the founders. That does not scale. The inbound interest is real, the pipeline is bigger than three founders can run properly, and every hour a founder spends in a procurement cycle is an hour not spent on the product.
You will take the motion the founders have built, make it yours, and make it repeatable across pharma, biotech and the partners around them. You will carry a number and be accountable for it.
We will be direct about the trade. There is no marketing engine feeding you, no established brand doing half the selling, and no playbook waiting in a folder. What there is: a genuinely differentiated product, founders who will get on any plane with you, and a market where pharma R&D leaders are actively looking for what we have built.
If that sounds like the good kind of hard, read on.
What you will do
This is a player-coach role with a BDR/BDM reporting to you. Your territory is the UK, EU and Switzerland: pharma first, then biotech, CROs and academic research institutes. Expect 25-40% travel to Basel, Cambridge, Copenhagen, Paris and Boston as needed.
Own the number. A new-business target owned end to end: pipeline generation, qualification, commercial negotiation and close.
Set account strategy. Decide which of the twenty or so pharma and biotech accounts that matter we go after first, in what order, and why. You build the account map and defend it.
Run complex enterprise deals. Multi-stakeholder cycles with R&D sponsors, data science evaluators, IT security, legal, procurement and often a data protection function.
Take pilots to production. Work with our forward deployed engineers and scientists to design pilots that can convert, then convert them. A pilot that impresses and dies is a failure, not a milestone.
Build partnerships. CROs, data providers, cloud and platform partners, and the consultancies already inside pharma R&D. You decide which relationships are worth building.
Shape commercial architecture. Pricing, packaging and contracting for a product new enough that the market has no reference price. You bring the field evidence and shape it with the CEO.
Close the feedback loop. Be the sharpest source of truth on what the market wants. Product expects to hear it from you weekly, unfiltered.
Keep the forecast honest. A CRM and a forecast the board can rely on. In a small company, a padded pipeline does real damage.
Your first twelve months
AI is moving at a speed unlike anything else before. You will be able to learn fast, but also take responsibility from day one to build a strong pipeline of customers.
You’ll get all the support to learn the product and buyers, sit on every customer call you can, and explain to R&D leadership why they should care about what we build. You will design the target account list and work with the CEO on qualified opportunities. Within your first months, you will own the pipeline and account plan and rapidly take responsibility to run deals end to end, with founders supporting you on the technical and visionary narrative only. You design the playbook that future BD hires will pick up.
What you will bring
A track record in life sciences enterprise sales. You have carried and hit a new-business target selling software or data products into pharma, biotech or life sciences R&D: six or seven figure annual contracts, long cycles, multiple decision makers. We will ask for quota, attainment and how much of it was yours.
Experience selling AI, data or analytics. Your buyers needed to trust the output before they would pay for it, and you know how to run a proof of value scoped to convert.
Credibility with scientists. Our buyers are bench scientists, computational biologists and R&D executives who will test whether you understand their problem within five minutes. You do not need a doctorate, but you do need real technical curiosity and the discipline to learn the domain properly.
Credibility on AI, without overselling. Our differentiation is rigour: evaluation, failure modes, what the system will not do. A seller who oversells us loses the second meeting.
A builder’s background. You have sold at a stage where you wrote your own materials, built your own list and made your own pricing calls.
Experience developing others. You have managed or mentored at least one junior seller and can show what changed because of it.
Nice to have
Early commercial hire at a techbio, AI or scientific software company that moved from founder-led sales to a real commercial function.
A scientific or technical degree, or a life sciences consulting background (MBB, L.E.K., ZS, IQVIA and similar).
A master’s or PhD in a life science discipline. Not required, but our buyers notice.
Existing relationships with R&D, digital or data leadership at large pharma.
Experience negotiating with pharma procurement, legal and information security, including data residency, GxP validation or EU AI Act questions.
A second European language, German above all.
This is probably not for you if
You want to manage a team from day one rather than sell. This is a hands-on role first; the team comes after the number.
Your strength is expanding and retaining accounts rather than opening them.
You need marketing-generated pipeline, an established brand or a mature playbook to be effective.
You have sold into life sciences, but never a product where AI or data was the thing being bought.
What we offer
Base salary of £110-135k, with OTE of £180-220k on a 60/40 base to variable split, benchmarked against European enterprise AI and techbio sales roles.
Meaningful equity, sized as an early commercial hire rather than a standard sales package. For the right person, this is the largest component over four years.
Uncapped commission that accelerates past target.
A guaranteed proportion of variable in year one while the pipeline is being built. We would rather you build the right pipeline than chase a bad deal in your first quarter.
Hybrid working from our Soho office, 2-3 days a week.
Interview process
Five stages, run in under three weeks. If you are in other processes, tell us and we will work to your timeline.
Intro call with Al Mortlock, Head of Talent (30 minutes).
Conversation with the CEO on the market, the buyer and the number (60 minutes).
Working session: present an account plan and a first-target thesis to two of the founders, and talk through how you would set up the BDR/BDM.
Technical grounding with a forward deployed engineer, plus a customer-scenario role play.
References, focused on quota attainment and how you behave in a hard quarter.